Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1).
Saved in:
| Title: | Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1). |
|---|---|
| Authors: | Campbell BC; Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia.; Department of Neurology, The Royal Melbourne Hospital, Parkville, VIC, Australia., Kasner SE; Division of Vascular Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Lista AD; DiaMedica Therapeutics Inc., Minnetonka, MN, USA., Volpi JJ; The Houston Methodist Institute for Academic Medicine, Houston, TX, USA., Kleinig TJ; Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia., Cordato D; Department of Neurology, Liverpool Hospital, Liverpool, NSW, Australia., Dewey HM; Department of Neurosciences, Eastern Health and Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia., Choi PM; Department of Neurosciences, Eastern Health and Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia., Garcia-Esperon C; Department of Neurology, Priority Research Centre for Brain and Mental Health Research, John Hunter Hospital, University of Newcastle, Newcastle, NSW, Australia., Sahathevan R; Deakin University and St. Vincent's Hospital Melbourne, Fitzroy, VIC, Australia., Wijeratne T; Department of Medicine and Neurology, Melbourne Medical School, The University of Melbourne and Western Health, Sunshine Hospital, St Albans, VIC, Australia., Wong AA; Department of Neurology, Royal Brisbane and Women's Hospital and the University of Queensland, Brisbane, QLD, Australia., Ghia D; Fiona Stanley Hospital, Perth, WA, Australia., Cloud GC; Department of Neuroscience, Alfred Hospital, Prahran, Victoria and Department of Neuroscience, School of Translational Medicine, Momash University, Melbourne, VIC, Australia., Giuffre M; University of Calgary, Departments of Pediatrics and Cardiology, Libin Cardiovascular Institute, Calgary, AB, Canada., Bath PM; Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, UK. |
| Corporate Authors: | ReMEDy1 Investigators |
| Source: | International journal of stroke : official journal of the International Stroke Society [Int J Stroke] 2026 Jul; Vol. 21 (6), pp. 861-870. Date of Electronic Publication: 2025 Nov 06. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101274068 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4949 (Electronic) Linking ISSN: 17474930 NLM ISO Abbreviation: Int J Stroke Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1747-4949 |
|---|---|
| DOI: | 10.1177/17474930251396480 |
